Review



giemsa stain kit  (Jiancheng Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Jiancheng Inc giemsa stain kit
    Giemsa Stain Kit, supplied by Jiancheng Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/giemsa+stain+kit/pmc13142038-152-23-26?v=Jiancheng+Inc
    Average 86 stars, based on 1 article reviews
    giemsa stain kit - by Bioz Stars, 2026-08
    86/100 stars

    Images



    Similar Products

    shandon wright giemsa stain kits  (Thermo Fisher)
    96
    Thermo Fisher shandon wright giemsa stain kits
    Shandon Wright Giemsa Stain Kits, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/giemsa+stain+kit/pm41686763-87-12-19?v=Thermo+Fisher
    Average 96 stars, based on 1 article reviews
    shandon wright giemsa stain kits - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    giemsa staining kit  (Nanjing Jiancheng Bioengineering Research Institute Co Ltd)
    86
    Nanjing Jiancheng Bioengineering Research Institute Co Ltd giemsa staining kit
    In vivo therapeutic effect of PECm-Allicin@LM. A Schematic of the treatment plan. B Peripheral blood smear subjected to <t>Giemsa</t> <t>staining</t> ( Pb ANKA-infected erythrocytes marked with a black arrow). C Survival curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). D Infection rate curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). E Weight curves for ICR mice in different groups ( n = 10). F Red blood cell count in peripheral blood samples from ICR mice in different groups ( n = 6). G Hemoglobin concentration in peripheral blood samples from ICR mice in different groups ( n = 6). H Appearance of livers from ICR mice in different groups. Data are presented as mean ± SEM, and * P < 0.05, ** P < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Giemsa Staining Kit, supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/giemsa+stain+kit/pmc13049907-57-1-7?v=Nanjing+Jiancheng+Bioengineering+Research+Institute+Co+Ltd
    Average 86 stars, based on 1 article reviews
    giemsa staining kit - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    giemsa stain kit  (Jiancheng Inc)
    86
    Jiancheng Inc giemsa stain kit
    In vivo therapeutic effect of PECm-Allicin@LM. A Schematic of the treatment plan. B Peripheral blood smear subjected to <t>Giemsa</t> <t>staining</t> ( Pb ANKA-infected erythrocytes marked with a black arrow). C Survival curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). D Infection rate curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). E Weight curves for ICR mice in different groups ( n = 10). F Red blood cell count in peripheral blood samples from ICR mice in different groups ( n = 6). G Hemoglobin concentration in peripheral blood samples from ICR mice in different groups ( n = 6). H Appearance of livers from ICR mice in different groups. Data are presented as mean ± SEM, and * P < 0.05, ** P < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Giemsa Stain Kit, supplied by Jiancheng Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/giemsa+stain+kit/pmc13142038-152-23-26?v=Jiancheng+Inc
    Average 86 stars, based on 1 article reviews
    giemsa stain kit - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    fast giemsa stain kit  (Yeasen Biotechnology)
    86
    Yeasen Biotechnology fast giemsa stain kit
    In vivo therapeutic effect of PECm-Allicin@LM. A Schematic of the treatment plan. B Peripheral blood smear subjected to <t>Giemsa</t> <t>staining</t> ( Pb ANKA-infected erythrocytes marked with a black arrow). C Survival curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). D Infection rate curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). E Weight curves for ICR mice in different groups ( n = 10). F Red blood cell count in peripheral blood samples from ICR mice in different groups ( n = 6). G Hemoglobin concentration in peripheral blood samples from ICR mice in different groups ( n = 6). H Appearance of livers from ICR mice in different groups. Data are presented as mean ± SEM, and * P < 0.05, ** P < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Fast Giemsa Stain Kit, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/giemsa+stain+kit/pm41899624-50-6-10?v=Yeasen+Biotechnology
    Average 86 stars, based on 1 article reviews
    fast giemsa stain kit - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    rapid giemsa staining kit  (Brickell Biotech)
    86
    Brickell Biotech rapid giemsa staining kit
    In vivo therapeutic effect of PECm-Allicin@LM. A Schematic of the treatment plan. B Peripheral blood smear subjected to <t>Giemsa</t> <t>staining</t> ( Pb ANKA-infected erythrocytes marked with a black arrow). C Survival curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). D Infection rate curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). E Weight curves for ICR mice in different groups ( n = 10). F Red blood cell count in peripheral blood samples from ICR mice in different groups ( n = 6). G Hemoglobin concentration in peripheral blood samples from ICR mice in different groups ( n = 6). H Appearance of livers from ICR mice in different groups. Data are presented as mean ± SEM, and * P < 0.05, ** P < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Rapid Giemsa Staining Kit, supplied by Brickell Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/giemsa+stain+kit/pmc13066626-272-26-30?v=Brickell+Biotech
    Average 86 stars, based on 1 article reviews
    rapid giemsa staining kit - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    a giemsa staining kit  (Yeasen Biotechnology)
    86
    Yeasen Biotechnology a giemsa staining kit
    Higher EOF in patients with glaucoma . ( a ) Flowchart of the EOFT. ( b ) Statistical results show the average concentration of NaCl at which RBCs displayed complete hemolysis (maximum resistance). The data are expressed as mean ± SEM. **** P < 0.0001; unpaired t -test. ( c ) Histogram of the NaCl concentrations of maximum resistance for patients with glaucoma and healthy controls. Each dot represents one patient with glaucoma or healthy control. ( d ) Representative image showing <t>Giemsa</t> <t>staining</t> of RBCs from patients with glaucoma and healthy controls. The data are expressed as mean ± SEM. **** P < 0.0001; unpaired t -test. ( e ) Quantification of the Giemsa staining result showing the percentage of abnormal RBCs in patients with glaucoma and healthy controls. ( f ) EOFT results for patients A and B with glaucoma and healthy control. ( g–h ) OCT results of patients A and B. INF, inferior; NAS, nasal; OD, right eye; OS, left eye; RNFL, retinal nerve fiber layer; SUP, superior; TEMP, temporal.
    A Giemsa Staining Kit, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/giemsa+stain+kit/pmc12882092-198-1-5?v=Yeasen+Biotechnology
    Average 86 stars, based on 1 article reviews
    a giemsa staining kit - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    In vivo therapeutic effect of PECm-Allicin@LM. A Schematic of the treatment plan. B Peripheral blood smear subjected to Giemsa staining ( Pb ANKA-infected erythrocytes marked with a black arrow). C Survival curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). D Infection rate curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). E Weight curves for ICR mice in different groups ( n = 10). F Red blood cell count in peripheral blood samples from ICR mice in different groups ( n = 6). G Hemoglobin concentration in peripheral blood samples from ICR mice in different groups ( n = 6). H Appearance of livers from ICR mice in different groups. Data are presented as mean ± SEM, and * P < 0.05, ** P < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Journal: International Journal of Pharmaceutics: X

    Article Title: Allicin-based biomimetic nanoparticles of the erythrocyte membrane for the delivery of lumefantrine to enhance its antimalarial effect

    doi: 10.1016/j.ijpx.2026.100487

    Figure Lengend Snippet: In vivo therapeutic effect of PECm-Allicin@LM. A Schematic of the treatment plan. B Peripheral blood smear subjected to Giemsa staining ( Pb ANKA-infected erythrocytes marked with a black arrow). C Survival curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). D Infection rate curves for Pb ANKA-infected ICR mice subjected to different treatments ( n = 10). E Weight curves for ICR mice in different groups ( n = 10). F Red blood cell count in peripheral blood samples from ICR mice in different groups ( n = 6). G Hemoglobin concentration in peripheral blood samples from ICR mice in different groups ( n = 6). H Appearance of livers from ICR mice in different groups. Data are presented as mean ± SEM, and * P < 0.05, ** P < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: A Giemsa staining kit was purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd. (China).

    Techniques: In Vivo, Staining, Infection, Cell Characterization, Concentration Assay

    Higher EOF in patients with glaucoma . ( a ) Flowchart of the EOFT. ( b ) Statistical results show the average concentration of NaCl at which RBCs displayed complete hemolysis (maximum resistance). The data are expressed as mean ± SEM. **** P < 0.0001; unpaired t -test. ( c ) Histogram of the NaCl concentrations of maximum resistance for patients with glaucoma and healthy controls. Each dot represents one patient with glaucoma or healthy control. ( d ) Representative image showing Giemsa staining of RBCs from patients with glaucoma and healthy controls. The data are expressed as mean ± SEM. **** P < 0.0001; unpaired t -test. ( e ) Quantification of the Giemsa staining result showing the percentage of abnormal RBCs in patients with glaucoma and healthy controls. ( f ) EOFT results for patients A and B with glaucoma and healthy control. ( g–h ) OCT results of patients A and B. INF, inferior; NAS, nasal; OD, right eye; OS, left eye; RNFL, retinal nerve fiber layer; SUP, superior; TEMP, temporal.

    Journal: Translational Vision Science & Technology

    Article Title: Increased Erythrocyte Osmotic Fragility as a Risk Factor for Predicting Glaucoma

    doi: 10.1167/tvst.15.2.4

    Figure Lengend Snippet: Higher EOF in patients with glaucoma . ( a ) Flowchart of the EOFT. ( b ) Statistical results show the average concentration of NaCl at which RBCs displayed complete hemolysis (maximum resistance). The data are expressed as mean ± SEM. **** P < 0.0001; unpaired t -test. ( c ) Histogram of the NaCl concentrations of maximum resistance for patients with glaucoma and healthy controls. Each dot represents one patient with glaucoma or healthy control. ( d ) Representative image showing Giemsa staining of RBCs from patients with glaucoma and healthy controls. The data are expressed as mean ± SEM. **** P < 0.0001; unpaired t -test. ( e ) Quantification of the Giemsa staining result showing the percentage of abnormal RBCs in patients with glaucoma and healthy controls. ( f ) EOFT results for patients A and B with glaucoma and healthy control. ( g–h ) OCT results of patients A and B. INF, inferior; NAS, nasal; OD, right eye; OS, left eye; RNFL, retinal nerve fiber layer; SUP, superior; TEMP, temporal.

    Article Snippet: The A Giemsa staining kit (Yeasen, China) was used to stain the smear following the manufacturer's instructions.

    Techniques: Concentration Assay, Control, Staining